Agenus: Making Another Effort With The FDA
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Börse:
2,527$
-3,16%
Echtzeit-Aktienkurs Agenus
Bid:
2,481$
Ask:
2,573$
Nachrichten zur Agenus Aktie
Why Agenus Stock Took Investors for a Wild Ride in 2021
A long-awaited regulatory event sent the biotechs shares on a roller-coaster ride last year....…
Agenus COO resigns to lead subsidiary MiNK Therapeutics
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Medical Officer verkauft Aktien von Agenus im Wert von 118.346$
Oday, Steven J. - Vorstand - Tag der Transaktion: 2022-01-06...…
Form 8-K AGENUS INC For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
2 Falling-Knife Stocks Actually Worth Buying Right Now
Adaptimmune Therapeutics and Agenus are having a tough go of it in the final quarter of 2021....…
Agenus inc (AGEN) Q3 2021 Earnings Call Transcript
AGEN earnings call for the period ending September 30, 2021....…
Agenus Posts Early Data For CTLA-4 Drug Candidate Across Tumor Types
read more...…
Why Agenus Was Rising High on Tuesday
The biotech delivers better-than-expected Q3 results....…
Agenus Inc. (AGEN) CEO Garo Armen on Q3 2021 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus (AGEN) Beats Q3 Earnings and Revenue Estimates
Agenus (AGEN) delivered earnings and revenue surprises of 50.00% and 38.15%, respectively, for the quarter ended September 2021. Do the…
Agenus up 8% premarket following Q3 2021 earnings beat
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus EPS beats by $0.26, beats on revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus Q3 2021 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus to Participate in Webcast Hosted by William Blair to Discuss AGEN1181 Clinical Data from SITC 2021 Meeting
LEXINGTON, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline…
Agenus to Provide Corporate Update and Third Quarter 2021 Financial Report
Conference Call on Tuesday, November 9, 2021, at 8:30 a.m. ET Conference Call on Tuesday, November 9, 2021, at 8:30…
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
Biotech stocks that fall hard on bad news can rebound in a flash....…
Agenus Shares Down 22% After Withdrawing BLA for Balstilimab
Agenus Shares Down 22% After Withdrawing BLA for Balstilimab...…
Agenus shares fall 15% after decision to withdraw balstilimab BLA
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus Provides Update on Balstilimab Development
LEXINGTON, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline…
Agenus Unit MiNK Set for Trading Debut After Downsized IPO >INKT
Agenus Unit MiNK Set for Trading Debut After Downsized IPO >INKT...…
Jensen: How to Play Agenus Using Options
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus to receive $20M from Bristol Myers as dosing starts for AGEN1777 study
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus Unit MiNK Therapeutics Sets IPO at 4 Million Shares >AGEN
Agenus Unit MiNK Therapeutics Sets IPO at 4 Million Shares >AGEN...…
Agenus to Present AGEN1181 Clinical Data at SITC
LEXINGTON, Mass., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…
MiNK Therapeutics: iNKT Cell Therapy Subsidiary Of Agenus Files For IPO
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be Presented at ESMO
LEXINGTON, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline…
Insiderhandel: PFO & PAO verkauft Aktien von Agenus im Wert von 72.280$
Klaskin, Christine M. - Vorstand - Tag der Transaktion: 2021-09-10...…
Insiderhandel: Chairman and CEO verkauft Aktien von Agenus im Wert von 533.696$
Armen, Garo H. - Vorstand - Tag der Transaktion: 2021-09-13...…
Agenus Cell-Therapy Unit MiNK Therapeutics Makes IPO Filing Public >AGEN
Agenus Cell-Therapy Unit MiNK Therapeutics Makes IPO Filing Public >AGEN...…
Agenus subsidiary inks collaboration agreement with Ginkgo Bioworks
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks
LEXINGTON, Mass. and BOSTON, Sept. 10, 2021 /PRNewswire/ -- Agenus Inc. ("Agenus"), an immuno-oncology company with an extensive pipeline of…
New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks
Development of saponin molecules designed to provide high-efficacy and long-lasting protection for pandemic vaccines Development of saponin molecules designed to…
Investors Cheer As Agenus Chugs Along
Shares of Agenus Inc. (AGEN), which have nearly doubled in value year-to-date, trade around $6....…
Agenus Multiple Value-Adding Events Ahead
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Agenus Fell by Over 4% on Monday
Investors were spooked by some ugly numbers in the companys latest earnings report....…
Agenus inc (AGEN) Q2 2021 Earnings Call Transcript
AGEN earnings call for the period ending June 30, 2021....…
Agenus (AGEN) Reports Q2 Loss, Misses Revenue Estimates
Agenus (AGEN) delivered earnings and revenue surprises of -54.17% and -36.75%, respectively, for the quarter ended June 2021. Do the…
Recap: Agenus Q2 Earnings
Shares of Agenus (NASDAQ:AGEN) moved higher by 2.1% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share…
AGENUS INC: 8-K Report
FORM 8-K...…
Agenus Corporate Update and Second Quarter 2021 Financial Report
LEXINGTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…
Agenus Q2 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AGENUS INC: 8-K Report
8-K...…
Agenus to Provide Corporate Update and Second Quarter 2021 Financial Report
Conference Call on Monday, August 9, 2021, at 8:30 a.m. ET Conference Call on Monday, August 9, 2021, at 8:30…
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
LEXINGTON, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline…
Agenus receives $200M payment as part of agreement with Bristol-Myers Squibb
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Agenus says its Bristol Myers Squibb licensing deal has up to $1.3 billion in milestone payments
Shares of Agenus Inc. were up 2.0% in premarket trading on Tuesday after the company said a licensing deal…
Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibody, AGEN1777
LEXINGTON, Mass., July 06, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive…
Agenus: What Now
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why Agenus Stock Is Marching Higher Today
The biotech took a major step toward becoming a commercial-stage cancer company....…